ATE554069T1 - Verwendung von tetrahydropyridinen zur behandlung von erkrankungen des zentralnervensystems - Google Patents

Verwendung von tetrahydropyridinen zur behandlung von erkrankungen des zentralnervensystems

Info

Publication number
ATE554069T1
ATE554069T1 AT07753023T AT07753023T ATE554069T1 AT E554069 T1 ATE554069 T1 AT E554069T1 AT 07753023 T AT07753023 T AT 07753023T AT 07753023 T AT07753023 T AT 07753023T AT E554069 T1 ATE554069 T1 AT E554069T1
Authority
AT
Austria
Prior art keywords
tetrahydropyridines
treatment
nervous system
central nervous
system diseases
Prior art date
Application number
AT07753023T
Other languages
English (en)
Inventor
Huw Davies
Anil Ratty
Original Assignee
Univ New York State Res Found
Chakra Biotech Pte Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found, Chakra Biotech Pte Ltd filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of ATE554069T1 publication Critical patent/ATE554069T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT07753023T 2006-03-10 2007-03-12 Verwendung von tetrahydropyridinen zur behandlung von erkrankungen des zentralnervensystems ATE554069T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US78124506P 2006-03-10 2006-03-10
PCT/US2007/006364 WO2007106508A2 (en) 2006-03-10 2007-03-12 Use of tetrahydropyridines in the treatment of central nervous system disorders

Publications (1)

Publication Number Publication Date
ATE554069T1 true ATE554069T1 (de) 2012-05-15

Family

ID=38510017

Family Applications (3)

Application Number Title Priority Date Filing Date
AT07752840T ATE490963T1 (de) 2006-03-10 2007-03-12 Tropan-prodrugs mit aktivität auf dem zns
AT07752887T ATE501143T1 (de) 2006-03-10 2007-03-12 Homotropane mit zns-aktivität
AT07753023T ATE554069T1 (de) 2006-03-10 2007-03-12 Verwendung von tetrahydropyridinen zur behandlung von erkrankungen des zentralnervensystems

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT07752840T ATE490963T1 (de) 2006-03-10 2007-03-12 Tropan-prodrugs mit aktivität auf dem zns
AT07752887T ATE501143T1 (de) 2006-03-10 2007-03-12 Homotropane mit zns-aktivität

Country Status (8)

Country Link
US (3) US7501453B2 (de)
EP (4) EP1996584B1 (de)
JP (4) JP2009529534A (de)
CN (4) CN101400676A (de)
AT (3) ATE490963T1 (de)
BR (3) BRPI0707096A2 (de)
DE (2) DE602007011043D1 (de)
WO (4) WO2007106423A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201408115SA (en) * 2014-12-05 2016-07-28 Chakra Biotech Pte Ltd Use of tetrahydropyridines in the treatment of sodium channel related disease and disorders
CN113292574B (zh) * 2020-02-21 2022-05-03 四川大学 一类手性多环的托品烷化合物及其制备方法和用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262428A (en) 1992-03-13 1993-11-16 Wake Forest University Biologically active tropane derivatives
US5760055A (en) * 1992-03-13 1998-06-02 Wake Forest University Biologically active tropane derivatives
US5227385A (en) * 1992-03-13 1993-07-13 Wake Forest University Method for treatment of neurodegenerative diseases
US5288872A (en) * 1992-03-13 1994-02-22 Wake Forest University Compounds for treatment of neurodegenerative diseases
US5591854A (en) 1994-10-14 1997-01-07 Wake Forest University Enantioselective synthesis of seven-membered carbocycles and tropanes
GB9605065D0 (en) 1996-03-11 1996-05-08 Merck Sharp & Dohme Therapeutic agents
US6013242A (en) 1998-01-13 2000-01-11 Wake Forest University Tropane derivatives with selective binding to the serotonin reuptake transporters for treatment of mental illness and as intermediates in the formation of imaging diagnostic agents for depression
US6331571B1 (en) * 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
SE9904724D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission I
WO2005037810A2 (fr) * 2003-10-17 2005-04-28 Sanofi-Aventis Derives de cyclopropylmethanones, leur preparation et leur utilisation en therapeutique
WO2007025144A1 (en) * 2005-08-24 2007-03-01 University Of Illinois - Chicago 5-ht2c receptor agonists as anorectic agents

Also Published As

Publication number Publication date
EP1998771A4 (de) 2009-11-11
DE602007011043D1 (de) 2011-01-20
WO2007106439A3 (en) 2008-10-30
US7851487B2 (en) 2010-12-14
DE602007013012D1 (de) 2011-04-21
EP2004591A1 (de) 2008-12-24
CN101400407A (zh) 2009-04-01
ATE490963T1 (de) 2010-12-15
JP2009536644A (ja) 2009-10-15
JP2009529535A (ja) 2009-08-20
JP2009529534A (ja) 2009-08-20
CN101400652A (zh) 2009-04-01
US20070249646A1 (en) 2007-10-25
WO2007106508A3 (en) 2008-11-27
US20070232646A1 (en) 2007-10-04
EP2004591A4 (de) 2009-11-11
US7432376B2 (en) 2008-10-07
BRPI0707093A2 (pt) 2011-04-19
WO2007106423A3 (en) 2008-07-24
EP1996584A2 (de) 2008-12-03
WO2007106423A2 (en) 2007-09-20
EP1996584A4 (de) 2009-09-01
CN101400642A (zh) 2009-04-01
WO2008127223A1 (en) 2008-10-23
EP1996194B1 (de) 2011-03-09
CN101400676A (zh) 2009-04-01
BRPI0707097A2 (pt) 2011-04-19
ATE501143T1 (de) 2011-03-15
US7501453B2 (en) 2009-03-10
BRPI0707096A2 (pt) 2011-04-19
EP1996194A2 (de) 2008-12-03
WO2007106508A2 (en) 2007-09-20
EP1998771B1 (de) 2012-04-18
EP1996194A4 (de) 2009-11-11
US20070244201A1 (en) 2007-10-18
JP2009529532A (ja) 2009-08-20
WO2007106439A2 (en) 2007-09-20
EP1998771A2 (de) 2008-12-10
EP1996584B1 (de) 2010-12-08

Similar Documents

Publication Publication Date Title
EA201001696A1 (ru) СОЕДИНЕНИЯ ХИНУКЛИДИНА В КАЧЕСТВЕ ЛИГАНДОВ НИКОТИНОВОГО АЦЕТИЛХОЛИНОВОГО РЕЦЕПТОРА α7
EA200970347A1 (ru) Соединения и композиции в качестве ингибиторов протеинкиназ
EA200801551A1 (ru) Применение сульфонамидных производных в лечении расстройств метаболизма и нервной системы
MA32393B1 (fr) Composés et compositions servant d'inhibiteurs de kinases
EA201100138A1 (ru) 4-феноксиметилпиперидины в качестве модуляторов активности gpr119
MX2010004494A (es) Uso de anticuerpos de trkb para el tratamiento de trastornos respiratorios.
AU2007257423A8 (en) Purine analogs
ATE416177T1 (de) Hetaryloxy-substituierte phenylaminopyrimidine als rho-kinasehemmer
EA201200686A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера
EA201071245A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера и связанных нарушений посредством модулирования реакции клеток на стресс
MX2009009592A (es) Aminopiridinas utiles como inhibidores de proteinas cinasas.
MX2013011908A (es) Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank.
EA201490540A1 (ru) Соединения и композиции в качестве ингибиторов с-kit киназы
ATE497961T1 (de) Als proteinkinaseinhibitoren geeignete verbindungen
BR112014004319A2 (pt) compostos e composições como inibidores de c-kit cinase
MX2010001486A (es) Derivados de tetrahidropiridin carboxamida como antagonistas de trpvl.
UY29077A1 (es) Amidas sustituidas de ácido tienopirrolcarboxílico, amidas del ácido pirrolotiazolcarboxílico y análogos relacionados como inhibidores de la caseína cinasa ie(epsilon)
MX2009006170A (es) Compuestos y composiciones como inhibidores de cinasa.
MX337849B (es) Composiciones y metodos para inhibicion de la via jak.
BR112012009121A2 (pt) Novas composições para a prevenção e/ou tratamento de distúrbios degenerativos do sistema nervoso central
ZA201003352B (en) Heterocyclic derivatives as modulators of ion channels
DE602006008583D1 (de) Stabile kristalline form von bifeprunoxmesylat, dosierungsformen davon und verfahren zu deren verwendung
MX2010009920A (es) Compuestos de azaindol para tratamiento de trastornos del sistema nervioso central.
MY164998A (en) Isoquinolinone derivatives as nk3 antagonists
ATE528309T1 (de) Als proteinkinaseinhibitoren geeignete verbindungen